🚀 VC round data is live in beta, check it out!

Lanxess Valuation Multiples

Discover revenue and EBITDA valuation multiples for Lanxess and similar public comparables like Solvac, National Industralization, Saudi Chemical, CAC Nantong Chemical Co and more.

Start Free TrialSee companies similar to Lanxess

Lanxess Overview

About Lanxess

Lanxess AG is a German chemical company that was originally spun out of Bayer. Lanxess has visibly decommoditised its portfolio by divesting its synthetic rubber business. It has business segments namely: specialty chemicals company in the fields of consumer protection chemicals, specialty additives, intermediates, and others. Geographically, it operates in EMEA (excluding Germany), Germany, Americas, and Asia-Pacific.

Founded

2004

HQ

Germany

Employees

12.3K

Sectors

Chemicals

Financials (LTM)

Revenue: $7B
EBITDA: $590M

EV

$5B

Valuation Multiples

Multiples.vc

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Lanxess Financials

Lanxess reported last 12-month revenue of $7B and EBITDA of $590M.

In the same LTM period, Lanxess generated $1B in gross profit, $590M in EBITDA, and had net loss of ($519M).

Revenue (LTM)

Lanxess P&L

In the most recent fiscal year, Lanxess reported revenue of $7B and EBITDA of $524M.

Lanxess expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Lanxess forward-looking valuation multiples
LTMNTMLast FYFY 2026FY 2027FY 2028
Revenue$7BXXX$7BXXXXXXXXX
Gross Profit$1BXXX$2BXXXXXXXXX
Gross Margin21%XXX20%XXXXXXXXX
EBITDA$590MXXX$524MXXXXXXXXX
EBITDA Margin9%XXX7%XXXXXXXXX
EBIT Margin(0%)XXX1%XXXXXXXXX
Net Profit($519M)XXX($208M)XXXXXXXXX
Net Margin(8%)XXX(3%)XXXXXXXXX
Net Debt——$3BXXXXXXXXX

Financial data powered by Morningstar, Inc.

Lanxess Stock Performance

Lanxess has current market cap of $2B, and enterprise value of $5B.

Market Cap Evolution

Lanxess' stock price is $21.28.

See Lanxess trading valuation data
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$5B$2B0.0%XXXXXXXXX$-2.41

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Lanxess Valuation Multiples

Lanxess trades at 0.7x EV/Revenue multiple, and 7.9x EV/EBITDA.

See valuation multiples for Lanxess and 15K+ public comps

EV / Revenue (LTM)

Lanxess Financial Valuation Multiples

As of April 19, 2026, Lanxess has market cap of $2B and EV of $5B.

Equity research analysts estimate Lanxess' 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Lanxess has a P/E ratio of (3.5x).

LTMNTMLast FYFY 2026FY 2027FY 2028
Market cap (current)$2BXXX$2BXXXXXXXXX
EV (current)$5BXXX$5BXXXXXXXXX
EV/Revenue0.7xXXX0.6xXXXXXXXXX
EV/EBITDA7.9xXXX8.9xXXXXXXXXX
EV/EBIT(376.1x)XXX78.9xXXXXXXXXX
EV/Gross Profit3.4xXXX3.0xXXXXXXXXX
P/E(3.5x)XXX(8.8x)XXXXXXXXX
EV/FCF(108.1x)XXX21.0xXXXXXXXXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Lanxess Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Lanxess Margins & Growth Rates

Lanxess' revenue in the last 12 month grew by 4%.

Lanxess' revenue per employee in the last FY averaged $0.6M, while opex per employee averaged $0.1M for the same period.

Lanxess' rule of 40 is 14% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Lanxess' rule of X is 21% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Lanxess and other 15K+ public comps

Lanxess Operational Valuation Multiples

LTMNTMLast FYFY 2026FY 2027FY 2028
Revenue Growth4%XXX(13%)XXXXXXXXX
EBITDA Margin9%XXX7%XXXXXXXXX
EBITDA Growth5%XXX12%XXXXXXXXX
Rule of 40—XXX14%XXXXXXXXX
Bessemer Rule of X—XXX21%XXXXXXXXX
Revenue per Employee—XXX$0.6MXXXXXXXXX
Opex per Employee—XXX$0.1MXXXXXXXXX
S&M Expenses to Revenue15%XXX14%XXXXXXXXX
G&A Expenses to Revenue4%XXX4%XXXXXXXXX
R&D Expenses to Revenue2%XXX2%XXXXXXXXX
Opex to Revenue—XXX20%XXXXXXXXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Digital TherapeuticsHorizontal MarketplacesInvestment BankingERP SoftwareDeveloper ToolsConsumer SaaSStreamingVertical SaaSNetworking HardwareFinancial Data & InformationEnergy StorageRoad InfrastructureSemiconductors
Explore Valuation Multiples by Industry

Lanxess Public Comps

See public comps and valuation multiples for other Chemicals comps.

EV/RevenueEV/EBITDA
LTM2026E2027ELTM2026E2027E
LanxessXXXXXXXXXXXXXXXXXX
SolvacXXXXXXXXXXXXXXXXXX
National IndustralizationXXXXXXXXXXXXXXXXXX
Saudi ChemicalXXXXXXXXXXXXXXXXXX
CAC Nantong Chemical CoXXXXXXXXXXXXXXXXXX
InnospecXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXX

Valuation data powered by FactSet, Inc.

Lanxess M&A Activity

Lanxess acquired XXX companies to date.

Last acquisition by Lanxess was on XXXXXXXX, XXXXX. Lanxess acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

See M&A valuation multiples

Latest Acquisitions by Lanxess

Acquired CompanyValuationEV/RevenueEV/EBITDA
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.

Start Free Trial

Lanxess Investment Activity

Lanxess invested in XXX companies to date.

Lanxess made its latest investment on XXXXXXXX, XXXXX. Lanxess invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).

See VC round multiples

Latest Investments by Lanxess

CompanyValuationEV/RevenueEV/EBITDA
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Lanxess

When was Lanxess founded?Lanxess was founded in 2004.
Where is Lanxess headquartered?Lanxess is headquartered in Germany.
How many employees does Lanxess have?As of today, Lanxess has over 12K employees.
Is Lanxess publicly listed?Yes, Lanxess is a public company listed on Frankfurt Stock Exchange.
What is the stock symbol of Lanxess?Lanxess trades under LXS ticker.
When did Lanxess go public?Lanxess went public in 2005.
Who are competitors of Lanxess?Lanxess main competitors are Solvac, National Industralization, Saudi Chemical, CAC Nantong Chemical Co.
What is the current market cap of Lanxess?Lanxess' current market cap is $2B.
What is the current revenue of Lanxess?Lanxess' last 12 months revenue is $7B.
What is the current revenue growth of Lanxess?Lanxess revenue growth (NTM/LTM) is 4%.
What is the current EV/Revenue multiple of Lanxess?Current revenue multiple of Lanxess is 0.7x.
Is Lanxess profitable?Yes, Lanxess is EBITDA-positive (as of the last 12 months).
What is the current EBITDA of Lanxess?Lanxess' last 12 months EBITDA is $590M.
What is Lanxess' EBITDA margin?Lanxess' last 12 months EBITDA margin is 9%.
What is the current EV/EBITDA multiple of Lanxess?Current EBITDA multiple of Lanxess is 7.9x.
What is the current FCF of Lanxess?Lanxess' last 12 months FCF is ($43M).
What is Lanxess' FCF margin?Lanxess' last 12 months FCF margin is (1%).
What is the current EV/FCF multiple of Lanxess?Current FCF multiple of Lanxess is (108.1x).

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial